Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Nuformix plc Nuformix plc

Nuformix plc

NFX
Helyezés a részvények között #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Részvényárfolyam
$0.00185055
Piaci kapitalizáció
$48.29K
Változás (1 nap)
-3.55%
Változás (1 év)
30.31%
Ország
GB
Kereskedés Nuformix plc (NFX)

Kategória

Healthcare
Nuformix plc (NFX) P/B aránya
P/B arány ekkor: September 2026 TTM: 2.01
Nuformix plc legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi könyv szerinti árfolyam aránya (P/B, TTM) 2.01. 2024 végén ez az arány 0.64 volt.
P/B arány története a(z) Nuformix plc esetén 2014 és 2026 között
P/B arány az év végén
Év P/B arány Változtassa meg
2026 (TTM) 2.01 -61.14%
2025 5.17 703.62%
2024 0.64 44.29%
2023 0.45 -63.79%
2022 1.23 -46.40%
2021 2.30 -42.90%
2020 4.02 28.15%
2019 3.14 93.67%
2018 1.62 -108.69%
2017 -18.66 -793.31%
2016 2.69 0.00%
2014 0.00 0.00%
P/B arány hasonló vállalatoknál vagy versenytársaknál
Vállalat P/B arány P/B arány különbség Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5144 224.23%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.5918 327.62%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9974 98.95%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3983 268.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH